Probi AB (OSTO:PROB) Receivables Turnover : 1.94 (As of Mar. 2024)

View and export this data going back to 1998. Start your Free Trial

What is Probi AB Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Probi AB's Revenue for the three months ended in Mar. 2024 was kr151.7 Mil. Probi AB's average Accounts Receivable for the three months ended in Mar. 2024 was kr78.3 Mil. Hence, Probi AB's Receivables Turnover for the three months ended in Mar. 2024 was 1.94.

Probi AB Receivables Turnover Historical Data

The historical data trend for Probi AB's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Probi AB Receivables Turnover Chart

Probi AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Receivables Turnover

Get a 7-Day Free Trial

6.61

8.21

6.12

5.66

6.95

Probi AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Receivables Turnover	Get a 7-Day Free Trial															1.63	1.32	1.44	1.56	1.94

Competitive Comparison of Probi AB's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Probi AB's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Probi AB's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Probi AB's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Probi AB's Receivables Turnover falls into.

Probi AB Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Probi AB's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

	Receivables Turnover (A: Dec. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2023 )	/ (	(Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )
=	627.687	/ (	(94.784	+	85.783)	/	2 )
=	627.687	/	90.2835
=	6.95

Probi AB's Receivables Turnover for the quarter that ended in Mar. 2024 is calculated as

	Receivables Turnover (Q: Mar. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Mar. 2024 )	/ (	(Accounts Receivable (Q: Dec. 2023 )	+	Accounts Receivable (Q: Mar. 2024 ))	/	count )
=	151.674	/ (	(85.783	+	70.806)	/	2 )
=	151.674	/	78.2945
=	1.94

Probi AB (OSTO:PROB) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Probi AB Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Probi AB's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Probi AB (OSTO:PROB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Probi AB (OSTO:PROB) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

PBBIF:USA

Address

Ideongatan 1 A, Lund, SWE, SE-223 70

Website

https://www.probi.com

Probi AB is engaged in probiotic research and development, manufacturing and sales of effective and well-documented probiotics. The company's research relates to living microorganisms with scientific health benefits. The main fields of research are gut health, immune system and nutrient absorption, iron absorption, bone health and stress and recovery. It operates in Consumer Healthcare (CHC) and Functional Food (FF). The company operates in United States, Americas, excluding the United States , Sweden, EMEA, excluding Sweden, and APAC. The company's business is divided into three operating segments. These segments are based on a geographical division and consist of the regions Americas (North and South America), EMEA (Europe, Middle East and Africa) and APAC (Asia and the Pacific).

Probi AB (OSTO:PROB) Headlines

No Headlines